Stock Screener App
Free
-
Play Store
App Store
Install
Install
Light
Dark
EN
Sign in
Watchlist
Top Lists
Markets
New
Charts
Options
Cryptos
Industries
Elite
Market Simulator
Products
PHAT
$5.69
3.23%
-0.19
Phathom Pharmaceuticals Inc (PHAT)
Indicator
5
EX
1min
5min
Hourly
Daily
Weekly
Monthly
Line
Candle
Full Chart
Overview
Price History
Option Chain
Financials
Discussions
Forecast
Phathom Pharmaceuticals Inc Stock (PHAT) Financials Data
Income Statement
Quarterly
*All numbers in millions
Period End Date
2026-09-30
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Period Length
3 Months
3 Months
3 Months
3 Months
3 Months
Revenues
14.07%
84.72
74.27
58.30
57.58
49.50
Cost Of Revenue
21.67%
18.37
15.10
12.00
7.65
6.19
Gross Profit
12.13%
66.36
59.18
46.31
49.94
43.31
Operating Expenses
5.22%
66.44
63.14
61.78
55.86
58.59
Selling, General, and Administrative
4.27%
57.70
55.33
54.01
48.37
51.56
Research and Development
11.93%
8.75
7.81
7.77
7.49
7.03
Operating Income/Loss
97.86%
-0.09
-3.97
-15.48
-5.93
-15.27
Nonoperating Income/Loss
1.43%
-13.81
-13.62
-14.89
-15.22
-14.70
Net Income/Loss
20.96%
-13.90
-17.58
-30.37
-21.15
-29.97
Attributable To Parent
20.96%
-13.90
-17.58
-30.37
-21.15
-29.97
Basic Average Shares
1.37%
84.89
83.75
82.05
0.30
73.40
Diluted Average Shares
1.37%
84.89
83.75
82.05
0.30
73.40
Basic Earnings Per Share
23.81%
-0.16
-0.21
-0.37
-0.27
-0.41
Diluted Earnings Per Share
23.81%
-0.16
-0.21
-0.37
-0.27
-0.41
Similar to PHAT
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters